Logo do repositório
 

Brazilian ibd study group position statement on sars-cov2 vaccination

Página do item simplificado
dc.contributor.authorQueiroz, Natália Sousa Freitas
dc.contributor.authorTeixeira, Fábio Vieira
dc.contributor.authorFreire, Caio Cesar Furtado
dc.contributor.authorMotta, Marina Pamponet
dc.contributor.authorDe Vasconcellos, Marcela Almeida Menezes
dc.contributor.authorChebli, Liliana Andrade
dc.contributor.authorHossne, Rogerio Saad [UNESP]
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionGastrosaúde – Clínica IBD
dc.contributor.institutionHospital Geral Cesar Cals
dc.contributor.institutionUniversidade Federal da Bahia (UFBA)
dc.contributor.institutionUniversidade Federal de Sergipe (UFS)
dc.contributor.institutionClínicas ambulatoriais IBD
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2021-06-25T11:15:20Z
dc.date.available2021-06-25T11:15:20Z
dc.date.issued2021-01-01
dc.description.abstractMass vaccination offers the best strategy to fight against COVID-19 pandemic, and SARS-CoV2 vaccines are being approved in several countries for emergency use. In Brazil, vaccine approval is expected in the next few days, however potential concerns exist regarding vaccine recommendations for specific populations, such as patients with inflammatory bowel disease (IBD). To address these questions, the Brazilian IBD Study Group (GEDIIB) provides this practical advice with key recommendations about the COVID-19 vaccines in IBD population.en
dc.description.affiliationDepartamento de Gastroenterologia Faculdade de Medicina da Universidade de São Paulo
dc.description.affiliationGastrosaúde – Clínica IBD
dc.description.affiliationHospital Geral Cesar Cals
dc.description.affiliationUniversidade Federal da Bahia Faculdade de Medicina
dc.description.affiliationUniversidade Federal de Sergipe Departamento de Medicina
dc.description.affiliationUniversidade Federal de Juiz de Fora (UFJF) Clínicas ambulatoriais IBD
dc.description.affiliationUniversidade Estadual Paulista (UNESP) Faculdade de Medicina de Botucatu
dc.description.affiliationUnespUniversidade Estadual Paulista (UNESP) Faculdade de Medicina de Botucatu
dc.format.extent2-4
dc.identifierhttp://dx.doi.org/10.1590/s0004-2803.202100000-02
dc.identifier.citationArquivos de Gastroenterologia, v. 58, n. 1, p. 2-4, 2021.
dc.identifier.doi10.1590/s0004-2803.202100000-02
dc.identifier.issn1678-4219
dc.identifier.issn0004-2803
dc.identifier.scopus2-s2.0-85105083787
dc.identifier.urihttp://hdl.handle.net/11449/208634
dc.language.isoeng
dc.relation.ispartofArquivos de Gastroenterologia
dc.sourceScopus
dc.titleBrazilian ibd study group position statement on sars-cov2 vaccinationen
dc.titlePosicionamento do Grupo de Estudos da Doença Inflamatória Intestinal do Brasil sobre a vacinação para SARS-CoV2pt
dc.typeArtigo
dspace.entity.typePublication
unesp.author.orcid0000-0003-2857-0825[1]
unesp.author.orcid0000-0002-8915-7279[2]
unesp.author.orcid0000-0002-7363-4579[3]
unesp.author.orcid0000-0002-7464-5448[4]
unesp.author.orcid0000-0001-5169-7395[5]
unesp.author.orcid0000-0002-7875-1475[6]
unesp.author.orcid0000-0002-8166-0304[7]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentCirurgia e Ortopedia - FMBpt

Arquivos

Coleções

Botucatu - FMB - Faculdade de Medicina